Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Promyelocytic Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07296445
What this trial is testing

A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301)

Who this might be right for
Acute Promyelocytic Leukemia (APL)Acute Promyelocytic LeukaemiaAcute Promyelocytic Leukemia With PML-RARA+6 more
SDK Therapeutics, Inc. 120
Not applicableUnknownNCT03096496
What this trial is testing

Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy

Who this might be right for
Acute Promyelocytic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 161
Not applicableActive Not RecruitingNCT07187505
What this trial is testing

Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia (APL)
Anhui Medical University 28
Large-scale testing (Phase 3)Study completedNCT00003934
What this trial is testing

Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Promyelocytic Leukemia (M3)Childhood Acute Promyelocytic Leukemia (M3)+2 more
National Cancer Institute (NCI) 420
Large-scale testing (Phase 3)UnknownNCT00002658
What this trial is testing

Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
LeukemiaNeutropenia
Medical Research Council 2,000
Early research (Phase 1)Study completedNCT00825487
What this trial is testing

Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic Malignancies

Who this might be right for
Metastatic Solid Tumors, Refractory/Relapsed Hematologic Malignancies
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 50
Post-approval studies (Phase 4)Study completedNCT00504764
What this trial is testing

Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)

Who this might be right for
Acute Promyelocytic Leukemia
PETHEMA Foundation 60
Testing effectiveness (Phase 2)Study completedNCT00004899
What this trial is testing

Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Northwestern University
Not applicableUnknownNCT02698124
What this trial is testing

Decitabine for Chemotherapy Unfit Korean AML Patients in Real Practice

Who this might be right for
Acute Myeloid LeukemiaElderlyIntensive Chemotherapy Unfit
Ulsan University Hospital 136
Not applicableActive Not RecruitingNCT00003861
What this trial is testing

Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

Who this might be right for
LeukemiaAcute Lymphoblastic LeukemiaAcute Promyelocytic Leukemia
Alliance for Clinical Trials in Oncology 840
Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Early research (Phase 1)Study completedNCT02086773
What this trial is testing

Red Cell Transfusion Goals in Patients With Acute Leukemias

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Lymphocytic Leukemia (ALL)Acute Myelogenous Leukemia (AML)+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 90
Testing effectiveness (Phase 2)Ended earlyNCT00184054
What this trial is testing

Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia

Who this might be right for
Acute Myelogenous Leukemia
University of Southern California 11
Post-approval studies (Phase 4)UnknownNCT00196768
What this trial is testing

Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic

Who this might be right for
Relapsed Acute Promyelocytic LeukemiaRefractory Acute Promyelocytic Leukemia
German AML Cooperative Group 30
Testing effectiveness (Phase 2)Ended earlyNCT00907582
What this trial is testing

ASCT for Relapsed APL After Molecular Remission

Who this might be right for
Acute Promyelocytic LeukemiaRelapse
Shanghai Jiao Tong University School of Medicine 5
Large-scale testing (Phase 3)UnknownNCT04175587
What this trial is testing

Randomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high-risk APL

Who this might be right for
Acute Promyelocytic Leukaemia
Peking University People's Hospital 109
Testing effectiveness (Phase 2)Study completedNCT01404949
What this trial is testing

Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy

Who this might be right for
Acute Promyelocytic Leukemia
Memorial Sloan Kettering Cancer Center 17
Post-approval studies (Phase 4)Study completedNCT00003398
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
AnemiaGraft Versus Host DiseaseLeukemia+3 more
University of Maryland, Baltimore 45
Early research (Phase 1)Study completedNCT00293410
What this trial is testing

Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic/Myeloproliferative Diseases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 70
Testing effectiveness (Phase 2)Study completedNCT00276601
What this trial is testing

Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Next Page